Brazilian singer Vanessa Rios passed away at 42 after a brave fight with pulmonary synovial sarcoma. Her death has deeply ...
Takara Bio Inc. (($JP:4974)) announced an update on their ongoing clinical study. Takara Bio Inc. has announced a new clinical study titled ...
The Food and Drug Administration granted accelerated approval for Adaptimmune Therapeutics’ cell therapy Tecelra in treating a specific form of cancer. The drug is on track to treat patients with ...
Fans across Brazil are mourning the heartbreaking loss of singer Vanessa Rios, who has died aged 42 after a brave fight with ...
FANS across Brazil are mourning the heartbreaking loss of singer Vanessa Rios, who has died aged 42 after a brave fight with ...
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Synovial Sarcoma pipeline constitutes 15+ key companies continuously working towards developing 20+ Synovial Sarcoma ...
Patients with advanced synovial sarcoma may have a new therapy option if the novel drug, afami-cel, is approved by the FDA after the priority review. The Food and Drug Administration (FDA) has ...
Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma - a rare tumor of soft tissues, such as ligaments and muscles - using an ...
Afami-cel, sold as Tecelra by Adaptimmune, is the first gene therapy to be approved for the rare form of cancer and the first FDA-approved T-cell receptor gene therapy. The accelerated approval was ...
The FDA has approved the gene therapy Tecelra for treatment of synovial sarcoma. Tecelra, developed by biopharmaceutical company Adaptimmune, is the first gene therapy treatment for adult patients ...
A new study published today in Cancer Discovery, a journal of the American Association for Cancer Research, reports findings that may change the understanding of how synovial sarcoma develops and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback